Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Toxicol ; 33(12): 1272-1283, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30255981

RESUMEN

OBJECTIVES: Colon cancer is the major health disease related with high mortality. Glycyrrhizic acid (GA) is an active constituent of licorice with anti-inflammatory and anticarcinogenesis effects. We investigated the chemopreventive potential of GA against 1,2-dimethylhydrazine (DMH)-induced colon tumorigenesis in Wistar rats. METHODS: Glycyrrhizic acid was administered orally at the dose of 15 mg/kg b.wt. and DMH was administered at the dose of 20 mg/kg b.wt. once a week for first 15 weeks. All the rats were euthanized after 30 weeks. GA supplementation significantly inhibited the tumor incidence and multiplicity. RESULTS: Glycyrrhizic acid treatment reduced the expression of Ki-67, proliferating cell nuclear antigen (PCNA), nuclear factor-kappa B (NF-kB), cyclooxygenase-2 (COX-2), induced nitric oxide synthase (iNOS), and vascular endothelial growth factor (VEGF) while enhanced the expression of p53, connexin-43, b-cell lymphoma-2 (Bcl-2), survivin, and cleaved caspase-3. Glycyrrhizic acid also significantly ameliorated DMH-induced decreased activities of caspase-9 and caspase-3. Furthermore, GA treatment reduced mast cells infiltration, attenuated the shifting of sialomucin to sulphomucin as well the levels of pro-inflammatory cytokines. CONCLUSION: The findings of the study suggest that GA has chemopreventive potential against DMH-induced colon tumorigenesis plausibly through the attenuation of hyperproliferative responses, pro-inflammatory cytokines level, inflammatory and angiogenic markers, and apoptotic responses.


Asunto(s)
Apoptosis/efectos de los fármacos , Carcinogénesis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Neoplasias del Colon/prevención & control , Ácido Glicirrínico/farmacología , Inflamación/prevención & control , Neovascularización Fisiológica/efectos de los fármacos , 1,2-Dimetilhidrazina , Animales , Anticarcinógenos/farmacología , Biomarcadores/análisis , Biomarcadores/metabolismo , Carcinogénesis/inducido químicamente , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/patología , Masculino , Ratas , Ratas Wistar
2.
PLoS One ; 8(2): e56020, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23457494

RESUMEN

BACKGROUND: Colon carcinogenesis is a multistep process and it emanates from a series of molecular and histopathological alterations. Glycyrrhizic acid (GA) is a natural and major pentacyclic triterpenoid glycoside of licorice roots extracts. It has several pharmacological and biological properties such as anti-inflammatory, anti-viral, and anti-cancer. In the present study, we investigated the chemopreventive potential of GA against 1,2-dimethyhydrazine (DMH)-induced precancerous lesions i.e., aberrant crypt foci (ACF) and mucin depleted foci (MDF), and its role in regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. METHODS: Animals were divided into 5 groups. In group III, IV and V, GA was administered at the dose of 15 mg/kg b. wt. orally while in group II, III and IV, DMH was administered subcutaneously in the groin at the dose of 20 mg/kg b.wt once a week for first 5 weeks and animals were euthanized after 9 weeks. RESULTS: GA supplementation suppressed the development of precancerous lesions and it also reduced the infiltration of mast cells, suppressed the immunostaining of Ki-67, NF-kB-p65, COX-2, iNOS and VEGF while enhanced the immunostaining of p53, connexin-43, caspase-9 and cleaved caspase-3. GA treatment significantly attenuated the level of TNF-α and it also reduced the depletion of the mucous layer as well as attenuated the shifting of sialomucin to sulphomucin. CONCLUSION: Our findings suggest that GA has strong chemopreventive potential against DMH-induced colon carcinogenesis but further studies are warranted to elucidate the precise mechanism of action of GA.


Asunto(s)
Focos de Criptas Aberrantes/prevención & control , Antiinflamatorios/uso terapéutico , Anticarcinógenos/uso terapéutico , Colon/efectos de los fármacos , Neoplasias Colorrectales/prevención & control , Ácido Glicirrínico/uso terapéutico , Focos de Criptas Aberrantes/inducido químicamente , Focos de Criptas Aberrantes/inmunología , Focos de Criptas Aberrantes/patología , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Colon/inmunología , Colon/patología , Neoplasias Colorrectales/inducido químicamente , Neoplasias Colorrectales/inmunología , Neoplasias Colorrectales/patología , Conexina 43/análisis , Conexina 43/inmunología , Dimetilhidrazinas , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/inmunología , Mastocitos/patología , Mucinas/análisis , Ratas , Ratas Wistar , Sialomucinas/análisis , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/inmunología
3.
Br J Nutr ; 110(4): 699-710, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23402272

RESUMEN

Diosmin (DM) is a naturally occurring flavone and has been found to possess numerous therapeutic properties. In this study, we used DM as a protective agent against the nephrotoxic effects of the environmental toxicant trichloroethylene (TCE). Male Wistar rats were divided into five groups (I-V, n 6). Groups II, III and IV received an oral administration of TCE at a dose of 1000 mg/kg body weight for twenty consecutive days. The animals in groups II and III received an oral treatment of DM at doses of 20 and 40 mg/kg body weight, respectively, for twenty consecutive days, while groups I and V were given maize oil (5 ml/kg body weight and DM 40 mg/kg body weight, respectively) for 20 d. The protective effects of DM on TCE-induced oxidative stress and caspase-dependent apoptosis were investigated by assaying oxidative stress biomarkers, lipid peroxidation (LPO), serum toxicity markers, alkaline unwinding assay, caspase-3, -7 and -9, Bax and p53 expression. Oral administration of TCE in rats enhanced renal LPO, depleted glutathione content and antioxidant enzymes, induced DNA strand breaks (P<0·001), modulated the expression of Bax and p53 protein and induced the expression of caspase-3, -7 and -9. Co-treatment with DM prevented oxidative stress by restoring the levels of antioxidant enzymes; furthermore, a significant dose-dependent decrease in DNA disintegration and kidney toxicity markers such as blood urea N, creatinine, lactate dehydrogenase and kidney injury molecule-1 was observed. DM also effectively decreased the TCE-induced up-regulation of Bax and p53. Data from the present study establish the protective role of DM against TCE-induced renal damage.


Asunto(s)
Diosmina/farmacología , Riñón/efectos de los fármacos , Tricloroetileno/toxicidad , Administración Oral , Animales , Antioxidantes/metabolismo , Caspasas/metabolismo , Catalasa/metabolismo , Daño del ADN , Suplementos Dietéticos , Riñón/lesiones , Peroxidación de Lípido , Masculino , Estrés Oxidativo , Sustancias Protectoras/farmacología , Ratas , Ratas Wistar , Proteína p53 Supresora de Tumor/metabolismo , Proteína X Asociada a bcl-2/metabolismo
4.
Mol Cell Biochem ; 374(1-2): 49-59, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23135684

RESUMEN

The growth and development of prostate gland is governed by testosterone. Testosterone helps in maintaining the adipose tissue stores of the body. It is well documented that with advancing age there has been a gradual decline in testosterone levels. Our aim was to study the protective role of daidzein on flutamide-induced androgen deprivation on matrix degrading genes, lipid profile and oxidative stress in Wistar rats. Sub-chronic (60 days) flutamide (30 mg/kg b.wt) administration resulted in marked increase in expressions of matrix degrading genes [matrix metalloproteases 9 and urokinase plasminogen activation receptor]. Additionally, it increased the levels of low density lipoproteins, total cholesterol, triglycerides, and lowered the levels of high density lipoproteins and endogenous antioxidant levels. Oral administration of daidzein (20 and 60 mg/kg b.wt) restituted the levels to normal. Daidzein administration resulted in amelioration of the prostate atrophy, degeneracy and invasiveness induced by flutamide. Our findings suggest that the daidzein may be given as dietary supplement to patients who are on androgen deprivation therapy, to minimize the adverse effects related to it and also retarding susceptibility of patients to cardiovascular diseases.


Asunto(s)
Isoflavonas/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Lípidos/biosíntesis , Metaloproteinasa 9 de la Matriz/metabolismo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Antagonistas de Andrógenos/administración & dosificación , Animales , Atrofia/tratamiento farmacológico , Catalasa/metabolismo , Colesterol/biosíntesis , Flutamida/administración & dosificación , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Lipoproteínas HDL/biosíntesis , Lipoproteínas LDL/biosíntesis , Masculino , Orquiectomía , Estrés Oxidativo/efectos de los fármacos , Fitoestrógenos/farmacología , Próstata/patología , Ratas , Ratas Wistar , Triglicéridos/biosíntesis
5.
Toxicology ; 302(2-3): 266-74, 2012 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-22981962

RESUMEN

It is well established that aberrant production of inflammatory mediators has been associated with most the toxic manifestations and the genesis of different chronic diseases including cancer. The basic aim of the present study is to investigate the effects of soy isoflavones (SIF) on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cutaneous inflammatory responses and to explore the underlying molecular mechanisms. We have studied the protective effects of SIF against TPA induced oxidative stress, pro-inflammatory cytokines level, activation of NF-κB, expression of COX-2 and ki-67 in mouse skin. Animals were divided into five groups I-V (n=6). Groups II, III and IV received topical application of TPA at the dose of 10 nmol/0.2 ml of acetone/animal/day, for 2 days. Animals of the groups III and IV were pre-treated with SIF 1.0 µg (D1) and 2.0 µg (D2) topically 30 min prior to each TPA administration, while groups I and V were given acetone (0.2 ml) and SIF (D2), respectively. We have found that SIF pretreatment significantly inhibited TPA induced oxidative stress, proinflammatory cytokines production and activation of NF-κB. SIF also inhibited the expression of COX-2 and ki-67. Histological findings further supported the protective effects of SIF against TPA-induced cutaneous damage. Thus, our results suggest that inhibitory effect of SIF on TPA-induced cutaneous inflammation includes inhibition of proinflammatory cytokines, attenuation of oxidative stress, activation of NF-κB and expression of COX-2.


Asunto(s)
Ciclooxigenasa 2/metabolismo , Genisteína/farmacología , Isoflavonas/farmacología , FN-kappa B/metabolismo , Piel/efectos de los fármacos , Acetato de Tetradecanoilforbol/efectos adversos , Animales , Proliferación Celular/efectos de los fármacos , Ciclooxigenasa 2/genética , Dermatitis/tratamiento farmacológico , Dermatitis/etiología , Femenino , Inflamación/tratamiento farmacológico , Inflamación/etiología , Antígeno Ki-67/genética , Antígeno Ki-67/metabolismo , Ratones , FN-kappa B/genética , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Piel/patología , Glycine max/química
6.
Br J Nutr ; 108(9): 1574-85, 2012 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-22309980

RESUMEN

Cisplatin (cis-diamminedichloroplatinum (II) (CDDP)) is a commonly used chemotherapeutic drug for the treatment of numerous forms of cancer, but it has pronounced adverse effects, namely nephrotoxicity, ototoxicity, neurotoxicity, hepatotoxicity, diarrhoea and nausea. CDDP-induced emesis and diarrhoea are also marked toxicities that may be due to intestinal injury. Chrysin (5,7-dihydroxyflavone), a natural flavone commonly found in many plants, possesses multiple biological activities, such as antioxidant and anti-inflammatory properties. In the present study, we investigated the protective effect of chrysin against CDDP-induced jejunal toxicity. The plausible mechanism of CDDP-induced jejunal toxicity includes oxidative stress, p53 and apoptosis via up-regulating the expression of caspase-6 and -3. Chrysin was administered to Wistar rats orally in maize oil. A single intraperitoneal injection of CDDP was given and the animals were killed after 24 h of CDDP injection. Chrysin ameliorated CDDP-induced lipid peroxidation, increase in xanthine oxidase activity, glutathione depletion, decrease in antioxidant (catalase, glutathione reductase, glutathione peroxidase and glucose-6-phosphate dehydrogenase) and phase-II detoxifying (glutathione-S-transferase and quinone reductase) enzyme activities. Chrysin attenuated CDDP-induced goblet cell disintegration, enhanced expression of p53 and apoptotic tissue damage. Histological findings further substantiated the protective effects of chrysin against CDDP-induced damage in the jejunum. The results of the present study demonstrate that oxidative stress and apoptosis are closely associated with CDDP-induced toxicity and chrysin shows the protective efficacy against CDDP-induced jejunum toxicity possibly via attenuating the oxidative stress and apoptotic tissue damage.


Asunto(s)
Antineoplásicos/efectos adversos , Antioxidantes/metabolismo , Cisplatino/efectos adversos , Flavonoides/metabolismo , Células Caliciformes/efectos de los fármacos , Yeyuno/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Animales , Antidiarreicos/metabolismo , Antidiarreicos/uso terapéutico , Antieméticos/metabolismo , Antieméticos/uso terapéutico , Antineoplásicos/antagonistas & inhibidores , Antioxidantes/uso terapéutico , Apoptosis/efectos de los fármacos , Cisplatino/antagonistas & inhibidores , Suplementos Dietéticos , Flavonoides/uso terapéutico , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Células Caliciformes/metabolismo , Células Caliciformes/patología , Yeyuno/metabolismo , Yeyuno/patología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Oxidorreductasas/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA